- Scientists have engineered a molecule, RcoM-HBD-CCC, which shows promise as the world's first fast-acting antidote for carbon monoxide poisoning.
- Carbon monoxide poisoning is a leading cause of accidental deaths globally, and current treatments, such as 100 per cent oxygen, are slow and often result in long-term health complications.
- The new protein-based molecule acts like a sponge, binding strongly to carbon monoxide and significantly reducing the time it takes to clear the gas from the blood compared to existing therapies.
- Pre-clinical studies in mice demonstrated that the molecule effectively removed carbon monoxide from red blood cells and was safely flushed from the body, with minimal impact on blood pressure.
- Researchers hope this intravenous antidote could be rapidly administered in emergency settings, though further pre-clinical research is needed to determine safe and effective dosages.
IN FULL
